MEDSIR’s PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side Effects in the Treatment of HER2-negative Advanced Breast Cancer
The PRIMED study found a way to reduce treatment-related side effects among participants, decreasing dose reductions, treatment interruptions, and permanent discontinuations. The strategic alliance between MEDSIR and Oncoclínicas has enabled the company to present 13 studies at the 2024 ASCO Annual
Vention to democratize industrial automation using NVIDIA AI technologies
MONTREAL, June 2, 2024 /PRNewswire/ – Vention, the company behind the cloud-based Manufacturing Automation Platform (MAP), today announced a collaboration with NVIDIA to bring industrial automation technology to small and medium manufacturers by using NVIDIA AI and accelerated computing to ad
Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
New security solution using NVIDIA NIM revealed at COMPUTEX DALLAS, June 2, 2024 /PRNewswire/ — Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today announced plans to demo a new data center solution, using NVIDIA technology, for security-conscious business and
Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
GUANGZHOU, China, June 2, 2024 /PRNewswire/ — Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will present a poster at the 2024 ASCO Annual Meeting entitled “Phase 1 study of BAT8006, a fo
OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
Kidney Cancer Research Aims to Enhance Metastatic Patient Management by Pinpointing Biomarker to Optimize Clinical Decision-Making BINYAMINA, Israel and CARY, N.C., June 2, 2024 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine for improved patient
Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
Top Fire watch organizations throughout the state of California SAN JOSE, Calif., June 2, 2024 /PRNewswire/ — Fast Guard Service, a leading provider of security guard services, has released “The Ultimate Guide to Choosing the Best Fire Watch Service.” This guide aims to assist busi
/R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Sunday, June 2, 2024/
OTTAWA, ON, June 1, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
/R E M I N D E R — Media Advisory – Deputy Prime Minister’s itinerary for Sunday, June 2, 2024/
OTTAWA, ON, June 1, 2024 /CNW/ – Note: All times local. Toronto, Ontario Private meetings. 12:30 p.m. The Deputy Prime Minister will tour a cultural centre and make an announcement. She will be joined by the Minister for Women and Gender Equality and Youth, Marci Ien. A media availability
Sunvozertinib’s Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
The global pivotal WU-KONG1B study investigating sunvozertinib achieved its primary objective with a manageable safety profile in relapsed or refractory NSCLC with EGFR exon20ins.An ongoing randomized global Phase III study (WU-KONG28) is assessing sunvozertinib versus platinum containing doublets i
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of its novel dr
